Wilhelm M, Krause U, Kovacs G
Abteilung Urologie, Ruprecht-Karls-University Heidelberg, Germany.
World J Urol. 1995;13(3):143-8. doi: 10.1007/BF00184868.
This review discusses the impact of molecular genetics on the diagnosis and prediction of the prognosis for renal-cell tumors. Through the use of molecular techniques, it has become possible to divide renal-cell tumors into genetically and biologically well-defined entities. The new classification has many advantages over morphological ones: (1) in contrary to tumor phenotype, genetic markers are constant during tumor progression and allow a precise diagnosis; (2) genetic analysis discriminates between papillary (multiple origin) and nonpapillary renal-cell carcinomas (solitary tumors); (3) genetic analysis allows a precise diagnosis of renal adenoma; (4) the new classification system offers a genetic prognostic system; and (5) the new diagnostic-prognostic system could easily be adapted to modern detection systems such as automated sequence and fragment-length analysis, which allow a quick and correct diagnosis with a high throughput.
本综述讨论了分子遗传学对肾细胞肿瘤诊断及预后预测的影响。通过分子技术的应用,已能够将肾细胞肿瘤分为基因和生物学上明确的实体。新分类法相对于形态学分类法具有诸多优势:(1)与肿瘤表型不同,基因标志物在肿瘤进展过程中是恒定的,可实现精确诊断;(2)基因分析可区分乳头状(多源性)和非乳头状肾细胞癌(孤立性肿瘤);(3)基因分析能够精确诊断肾腺瘤;(4)新分类系统提供了一个基因预后系统;(5)新的诊断-预后系统可轻松适配现代检测系统,如自动化序列和片段长度分析,从而实现高通量的快速准确诊断。